Clinical Trials Directory

Trials / Terminated

TerminatedNCT06650670

Effect of Consuming a Bioactive Compound (EPP) on Joint Health in Healthy Adults

Randomized, Double-blind, Controlled Nutritional Intervention Study of Parallel Groups to Evaluate the Effect of Consuming a Bioactive Compound (EPP) on Joint Health in Healthy Adults

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Biosearch S.A. · Industry
Sex
All
Age
35 Years – 65 Years
Healthy volunteers
Accepted

Summary

The objective of this trial is to determine the efficacy of oral administration of a bioactive compound (EPP) in healthy individuals with mild knee joint discomfort.

Detailed description

It is estimated that the incidence of osteoarthritis (OA) is increasing exponentially worldwide, with serious consequences, not only on the quality of life and functionality of the subjects, but also a high burden on the social and health care systems of the countries. Existing treatments for OA are either invasive, and therefore risky for the subject and high cost, or have side effects and cannot be maintained over time. Therefore, there is a high demand to find effective and safe therapies to prevent and/or treat OA, such as functional ingredients or compounds present in food. In this regard, our experimental bioactive compound has been developed and shown to be safe and effective in reducing joint pain and improving quality of life in a previous study. The aim of this study is to evaluate the effect of the consumption of our bioactive compound, in healthy Spanish individuals with mild joint discomfort in the knee.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDietary Supplement: PlaceboEach participant will consume 2 capsules per day in one of the main meals without any restriction in the diet or in their life habits
DIETARY_SUPPLEMENTDietary Supplement: EPPEach participant will consume 2 capsules per day in one of the main meals without any restriction in the diet or in their life habits

Timeline

Start date
2022-12-01
Primary completion
2023-08-01
Completion
2023-12-15
First posted
2024-10-21
Last updated
2024-10-21

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06650670. Inclusion in this directory is not an endorsement.